Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
282.99
-3.48 (-1.21%)
Mar 3, 2026, 4:00 PM EST - Market closed
Labcorp Holdings Revenue
In the year 2025, Labcorp Holdings had annual revenue of $13.95B with 7.25% growth. Labcorp Holdings had revenue of $3.52B in the quarter ending December 31, 2025, with 5.60% growth.
Revenue (ttm)
$13.95B
Revenue Growth
+7.25%
P/S Ratio
1.67
Revenue / Employee
$196,503
Employees
71,000
Market Cap
23.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.95B | 942.80M | 7.25% |
| Dec 31, 2024 | 13.01B | 847.30M | 6.97% |
| Dec 31, 2023 | 12.16B | 297.70M | 2.51% |
| Dec 31, 2022 | 11.86B | -1.27B | -9.68% |
| Dec 31, 2021 | 13.14B | -842.40M | -6.03% |
| Dec 31, 2020 | 13.98B | 2.42B | 20.98% |
| Dec 31, 2019 | 11.55B | 221.40M | 1.95% |
| Dec 31, 2018 | 11.33B | 1.03B | 9.95% |
| Dec 31, 2017 | 10.31B | 755.10M | 7.90% |
| Dec 31, 2016 | 9.55B | 872.80M | 10.06% |
| Dec 31, 2015 | 8.68B | 2.67B | 44.39% |
| Dec 31, 2014 | 6.01B | 203.30M | 3.50% |
| Dec 31, 2013 | 5.81B | 136.90M | 2.41% |
| Dec 31, 2012 | 5.67B | 129.10M | 2.33% |
| Dec 31, 2011 | 5.54B | 538.40M | 10.76% |
| Dec 31, 2010 | 5.00B | 309.20M | 6.59% |
| Dec 31, 2009 | 4.69B | 189.50M | 4.21% |
| Dec 31, 2008 | 4.51B | 437.00M | 10.74% |
| Dec 31, 2007 | 4.07B | 477.40M | 13.30% |
| Dec 31, 2006 | 3.59B | 263.20M | 7.91% |
| Dec 31, 2005 | 3.33B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 16.31B |
| Quest Diagnostics | 11.04B |
| Agilent Technologies | 7.07B |
| Illumina | 4.34B |
| IDEXX Laboratories | 4.30B |
| Mettler-Toledo International | 4.03B |
| Exact Sciences | 3.25B |
| Waters | 3.17B |
LH News
- 8 days ago - Labcorp Expands Collaboration with PathAI to Deploy FDA-Cleared Digital Pathology Platform Nationwide - PRNewsWire
- 14 days ago - Labcorp Holdings Inc. (LH) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Labcorp forecasts upbeat annual profit on strong demand for diagnostic products - Reuters
- 14 days ago - Labcorp Announces 2025 Fourth Quarter and Full Year Results - PRNewsWire
- 20 days ago - Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care - PRNewsWire
- 22 days ago - Labcorp Appoints John H. Sampson, M.D. - PRNewsWire
- 6 weeks ago - Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026 - PRNewsWire
- 6 weeks ago - Labcorp Declares Quarterly Dividend - PRNewsWire